Interleukin-12 up-regulates perforin- and Fas-mediated lymphokine-activated killer activity by intestinal intraepithelial lymphocytes

Clinical and Experimental Immunology

Volumn 138, Issue 2, 2004, Pages 259-265

  Ebert, E C ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cytotoxicity; Fas; Intraepithelial lymphocytes; Perforin; TNF

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CONCANAMYCIN A; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PERFORIN; SERINE PROTEINASE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL STRAIN HT29; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTESTINE EPITHELIUM CELL; INTRAEPITHELIAL LYMPHOCYTE; JEJUNUM MUCOSA; LEUKEMIA CELL LINE; LYMPHOKINE ACTIVATED KILLER CELL; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD94; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EPITHELIAL CELLS; FAS LIGAND PROTEIN; HUMANS; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-2; INTESTINAL MUCOSA; JEJUNUM; KILLER CELLS, LYMPHOKINE-ACTIVATED; LECTINS, C-TYPE; LIGANDS; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 8144221014     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02614.x     Document Type: Article

References (34)

1. Corazza N, Muller S, Brunner T, Kagi D, Mueller C. Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal IELs. J Immunol 2000; 164:398-403.
2. + gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J Immunol 1994; 153:4596.
3. + murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in Fas-based cytotoxicity. J Immunol 1996; 156:35-41.
4. +T lymphocytes. Immunology 2002; 106:476-85.
5. Taunk J, Roberts AI. Ebert EC. Spontaneous cytotoxicity of human intraepithelial lymphocytes against epithelial cell tumors. Gastroenterology 1992; 102:69-75.
6. Ebert EC. IL-15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology 1998; 115:1439-45.
7. Mention J-J, Ahmed MB, Begue B et al. IL-15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003; 125:730-45.
8. + intestinal intraepithelial lymphocytes. J Immunol 1999; 163:5843-50.
9. Inagaki-Ohara K, Nishimura H, Mitani A et al. Interleukin 15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing γδ T cell receptor in mice. Eur J Immunol 1997; 27:2885-91.
10. Hirose K, Suzuki H, Nishimura H et al. Interleukin 15 may be responsible for early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats. Infect Immun 1998; 66:5677-83.
11. Zhan Y, Cheers C. Control of IL-12 and IFN-γ production in response to live or dead bacteria by TNF and other factors. J Immunol 1998; 161:1447-53.
12. + T cells in the absence of TCR ligation. J Immunol 1998; 161:3408-15.
13. Locksley RM. IL-12 in host defense against microbial pathogens. Proc Natl Acad Sci USA 1993; 90:5879-80.
14. Monteleone G, Biancone L, Marasco R et al. IL-12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112:1169-78.
15. Liu Z, Geboes K, Heremans H et al. Role of IL-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis. Eur J Immunol 2001; 37:1550-60.
16. Guy-Grand D, DiSanto JP, Henchoz P, Malassis-Seris M, Vassalli P. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFNγ, TNF) in the induction of epithelial cell death and renewal. Eur J Immunol 1998; 28:730-44.
17. Hashimoto W, Osaki T, Okamura H et al. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J Immunol 1999; 163:583-9.
18. Cesano A, Visonneau S, Clark SC, Santoli D. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J Immunol 1993; 151:2943-57.
19. Bonnema JD, Rivlin KA, Ting AT, Schoon RA, Abraham RT, Leibson PJ. Cytokine-enhanced NK cell-mediated cytotoxicity. J Immunol 1994; 152:2098-104.
20. + T cells in IL-12-induced immune responses in vivo. J Immunol 1998; 160:16-9.
21. + T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer. J Immunol 1999; 162:609-17.
22. Nastala CL, Edington HD, McKinney TG et al. Recombinant IL-12 administration induces tumor regression in association with IFN/production. J Immunol 1994; 153:1697-706.
23. Brunda MJ, Luistro L, Warrier RR et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993; 178:1223-30.
24. Cui J, Shin T, Kawano T et al. Requirement for Vα14NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278:1623-6.
25. Jabri B, Selby JM, Hegulescu H et al. TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity 2002; 17:487-99.
26. Garcia P, Llano M, de Heredia AB et al. Human T cell receptor-mediated recognition of HLA-E. Eur J Immunol 2002; 32:936-44.
27. Lieto LD, Borrego F, You C-H, Coligan JE. Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15. J Immunol 2003; 171:5277-86.
28. Ebert EC. Proliferative responses of human intraepithelial lymphocytes to various T-cell stimuli. Gastroenterology 1989; 97:1372-81.
29. Chang J, Cho J-H, Lee S-W, Choi S-Y, Ha S-J, Sung Y-C. IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. J Immunol 2004; 172:2818-26.
30. Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER. Perforin, fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol 1996; 157:1919-25.
31. Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 1999; 5:90-6.
32. Barry M, Bleackley RC. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev 2002; 2:401-9.
33. Ciccocioppo R, DiSabatino A, Parroni R et al. Cytolytic mechanisms of intraepithelial lymphocytes in celiac disease. Clin Exp Immunol 2000; 120:235-40.
34. Merger M, Viney JL, Borojevic R et al. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine. Gut 2002; 51:155-63.